Protalix BioTherapeutics, Inc. Convertible Debt, Noncurrent
Protalix BioTherapeutics, Inc. (PLX) had Convertible Debt, Noncurrent of $20.13 million as of 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2024-03-14
- 2023-06-30: Convertible Debt, Noncurrent $20.13M.
- 2023-03-31: Convertible Debt, Noncurrent $28.27M.
- 2022-12-31: Convertible Debt, Noncurrent $28.19M.
- 2022-09-30: Convertible Debt, Noncurrent $28.11M.
| Period end | Convertible Debt, Noncurrent | Convertible Debt, Noncurrent as first filed |
|---|---|---|
| 2023-06-30 | $20.13M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $28.27M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $28.19M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $28.11M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $28.03M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $27.96M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $27.89M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $27.82M 10-Q · filed 2021-11-15 | |
| 2020-09-30 | $53.51M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $52.62M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $51.78M 10-Q · filed 2020-06-01 | |
| 2019-12-31 | $50.96M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $50.16M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $49.40M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $48.67M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $47.97M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $47.32M 10-Q · filed 2019-03-18 | |
| 2018-06-30 | $46.74M 10-Q · filed 2019-03-18 | |
| 2018-03-31 | $46.11M 10-Q · filed 2019-03-18 | |
| 2017-12-31 | $46.27M 10-Q · filed 2019-03-18 | |
| 2017-09-30 | $53.63M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $53.58M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $113.20M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $19.34M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $68.13M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $68.02M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $67.91M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $67.80M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $67.77M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $67.67M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $67.57M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $67.35M 10-K · filed 2016-03-08 | $67.46M 10-K · filed 2015-03-12 |
| 2014-09-30 | $67.36M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $67.25M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $67.15M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $67.05M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $66.94M 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |